[
  {
    "ts": "2025-11-10T13:55:00+00:00",
    "headline": "AIM ImmunoTech Details New UPMC Abstract on Completed Clinical Trial Involving Ampligen’s Synergistic Potential in the Treatment of Advanced Recurrent Ovarian Cancer",
    "summary": "OCALA, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today detailed a recent abstract containing data from the completed Phase 2 advanced recurrent ovarian cancer clinical study utilizing Ampligen (rintatolimod), which was presented at the 40th Annual SITC Meeting on November 7, 2025, at National Harbor, MD. Platinum-sensitive patients with measurable peritoneal disease were eligible for combination therapy with up to six treatment cycl",
    "url": "https://finance.yahoo.com/news/aim-immunotech-details-upmc-abstract-135500588.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "7f91c66c-ba90-3148-ae69-da38a5d9e7b9",
      "content": {
        "id": "7f91c66c-ba90-3148-ae69-da38a5d9e7b9",
        "contentType": "STORY",
        "title": "AIM ImmunoTech Details New UPMC Abstract on Completed Clinical Trial Involving Ampligen’s Synergistic Potential in the Treatment of Advanced Recurrent Ovarian Cancer",
        "description": "",
        "summary": "OCALA, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today detailed a recent abstract containing data from the completed Phase 2 advanced recurrent ovarian cancer clinical study utilizing Ampligen (rintatolimod), which was presented at the 40th Annual SITC Meeting on November 7, 2025, at National Harbor, MD. Platinum-sensitive patients with measurable peritoneal disease were eligible for combination therapy with up to six treatment cycl",
        "pubDate": "2025-11-10T13:55:00Z",
        "displayTime": "2025-11-10T13:55:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/3c34f5042d0444d8a15493a212dc7a7f",
          "originalWidth": 753,
          "originalHeight": 402,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w9E.7KpDMw2q6tN.EtcY9w--~B/aD00MDI7dz03NTM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/3c34f5042d0444d8a15493a212dc7a7f.cf.webp",
              "width": 753,
              "height": 402,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/43LBgV9Cpb0dcXxHYuW4fQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/3c34f5042d0444d8a15493a212dc7a7f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/aim-immunotech-details-upmc-abstract-135500588.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/aim-immunotech-details-upmc-abstract-135500588.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "0A4Y.L"
            },
            {
              "symbol": "AIM"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-10T13:54:00+00:00",
    "headline": "Bristol Myers Gains 7.2% in a Month:  Buy, Sell or Hold the Stock?",
    "summary": "Bristol Myers Squibb's strong Q3 driven by soaring demand for Opdivo, Reblozyl, Breyanzi and Camzyos pushes shares up 7.2% in a month.",
    "url": "https://finance.yahoo.com/news/bristol-myers-gains-7-2-135400428.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "6ef2afa4-42dc-373e-ace9-01f0c0da1376",
      "content": {
        "id": "6ef2afa4-42dc-373e-ace9-01f0c0da1376",
        "contentType": "STORY",
        "title": "Bristol Myers Gains 7.2% in a Month:  Buy, Sell or Hold the Stock?",
        "description": "",
        "summary": "Bristol Myers Squibb's strong Q3 driven by soaring demand for Opdivo, Reblozyl, Breyanzi and Camzyos pushes shares up 7.2% in a month.",
        "pubDate": "2025-11-10T13:54:00Z",
        "displayTime": "2025-11-10T13:54:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AZ1NFKr1Arip4UWINeWStw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zL5_evNVQm1N5N.bc6WldQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-gains-7-2-135400428.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-gains-7-2-135400428.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-10T14:48:00+00:00",
    "headline": "Will Keytruda Aid MRK's Growth in 2026 After a Subdued Q3?",
    "summary": "Merck leans on Keytruda's expanding cancer indications and new SC formulation to sustain growth momentum into 2026 after soft sales in Q3.",
    "url": "https://finance.yahoo.com/news/keytruda-aid-mrks-growth-2026-144800572.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "19bf9509-fa53-3dcd-8f32-e3d8e582a585",
      "content": {
        "id": "19bf9509-fa53-3dcd-8f32-e3d8e582a585",
        "contentType": "STORY",
        "title": "Will Keytruda Aid MRK's Growth in 2026 After a Subdued Q3?",
        "description": "",
        "summary": "Merck leans on Keytruda's expanding cancer indications and new SC formulation to sustain growth momentum into 2026 after soft sales in Q3.",
        "pubDate": "2025-11-10T14:48:00Z",
        "displayTime": "2025-11-10T14:48:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/df847a6f57145ec8b42be7c65f980057",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EfDoN3QVRYGCfRDweFAACw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/df847a6f57145ec8b42be7c65f980057.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JwDxubmjtiCRyiYBqVh9AQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/df847a6f57145ec8b42be7c65f980057.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/keytruda-aid-mrks-growth-2026-144800572.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/keytruda-aid-mrks-growth-2026-144800572.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-10T17:32:09+00:00",
    "headline": "Top 3 Dividend Stocks To Enhance Your Portfolio",
    "summary": "As the U.S. stock market shows signs of optimism with major indexes rebounding on hopes for a resolution to the government shutdown, investors are keenly observing opportunities to strengthen their portfolios. In such an environment, dividend stocks can offer a compelling mix of income and stability, making them an attractive option for those looking to enhance their investment strategy amidst ongoing economic developments.",
    "url": "https://finance.yahoo.com/news/top-3-dividend-stocks-enhance-173209753.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "c96d9861-c9a8-3c33-8be7-f515daf21fd0",
      "content": {
        "id": "c96d9861-c9a8-3c33-8be7-f515daf21fd0",
        "contentType": "STORY",
        "title": "Top 3 Dividend Stocks To Enhance Your Portfolio",
        "description": "",
        "summary": "As the U.S. stock market shows signs of optimism with major indexes rebounding on hopes for a resolution to the government shutdown, investors are keenly observing opportunities to strengthen their portfolios. In such an environment, dividend stocks can offer a compelling mix of income and stability, making them an attractive option for those looking to enhance their investment strategy amidst ongoing economic developments.",
        "pubDate": "2025-11-10T17:32:09Z",
        "displayTime": "2025-11-10T17:32:09Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/75a6275a0d81fd5fbc47ebecee672e4c",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/GtOHmHb7ARVdAFXcUOUznw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/75a6275a0d81fd5fbc47ebecee672e4c.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CbeCLvAoO9qtHaSiLUwLfg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/75a6275a0d81fd5fbc47ebecee672e4c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/top-3-dividend-stocks-enhance-173209753.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/top-3-dividend-stocks-enhance-173209753.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFBC"
            },
            {
              "symbol": "DGICB"
            },
            {
              "symbol": "INDB"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "PFS"
            },
            {
              "symbol": "HTBK"
            },
            {
              "symbol": "PEBO"
            },
            {
              "symbol": "FIBK"
            },
            {
              "symbol": "FMNB"
            },
            {
              "symbol": "EBF"
            },
            {
              "symbol": "PLOW"
            },
            {
              "symbol": "COLB"
            },
            {
              "symbol": "CZNC"
            },
            {
              "symbol": "DGICA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-10T21:20:00+00:00",
    "headline": "Merck’s Heart Pill Slashes Cholesterol Levels in Test Patients",
    "summary": "The daily pill reduced LDL cholesterol by 56% in just six months, among patients whose LDL defy treatment with everyday statin drugs.",
    "url": "https://www.barrons.com/articles/mercks-heart-pill-cholesterol-stock-8be3690d?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "8388595e-0aff-3659-9831-abe2edbce94f",
      "content": {
        "id": "8388595e-0aff-3659-9831-abe2edbce94f",
        "contentType": "STORY",
        "title": "Merck’s Heart Pill Slashes Cholesterol Levels in Test Patients",
        "description": "",
        "summary": "The daily pill reduced LDL cholesterol by 56% in just six months, among patients whose LDL defy treatment with everyday statin drugs.",
        "pubDate": "2025-11-10T21:20:00Z",
        "displayTime": "2025-11-10T21:20:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/8388595e-0aff-3659-9831-abe2edbce94f/merck%E2%80%99s-heart-pill-slashes.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/d7855a853ab4a8287445ae3be33a812c",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.C05mXQfhr7IGzf2qxHGiQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/d7855a853ab4a8287445ae3be33a812c.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yFFgGmHyx9aTAK5_3z5iQg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/d7855a853ab4a8287445ae3be33a812c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/mercks-heart-pill-cholesterol-stock-8be3690d?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "IONS"
            },
            {
              "symbol": "CRSP"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "REGN"
            },
            {
              "symbol": "SAN.PA"
            },
            {
              "symbol": "NOVN.SW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]